Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03800147Unknown
Randomised, open-label trial of escherichia coli nissle 1917 in Escherichia coli infection and Salmonella Typhimurium infection, sponsored by University of Zurich. Primary endpoint: Maximum concentration of E. coli Nissle bacteriae in all stool samples at 5 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03800147.